281 related articles for article (PubMed ID: 12441257)
1. Neoadjuvant endocrine therapy of breast cancer: a surgical perspective.
Dixon JM; Anderson TJ; Miller WR
Eur J Cancer; 2002 Nov; 38(17):2214-21. PubMed ID: 12441257
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes.
Dixon JM; Jackson J; Renshaw L; Miller WR
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):295-9. PubMed ID: 14623524
[TBL] [Abstract][Full Text] [Related]
3. Role of endocrine therapy in the neoadjuvant surgical setting.
Dixon JM
Ann Surg Oncol; 2004 Jan; 11(1 Suppl):18S-23S. PubMed ID: 15015705
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant use of endocrine therapy in breast cancer.
Macaskill EJ; Dixon JM
Breast J; 2007; 13(3):243-50. PubMed ID: 17461898
[TBL] [Abstract][Full Text] [Related]
5. Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapy.
Smith IE
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):289-93. PubMed ID: 14623523
[TBL] [Abstract][Full Text] [Related]
6. Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?
Freedman OC; Verma S; Clemons MJ
Cancer Treat Rev; 2005 Feb; 31(1):1-17. PubMed ID: 15707700
[TBL] [Abstract][Full Text] [Related]
7. [Neoadjuvant endocrine therapy for locally advanced breast cancer].
Viola G; Sergi D; Conti F; Lopez M
Clin Ter; 2007; 158(5):441-52. PubMed ID: 18062352
[TBL] [Abstract][Full Text] [Related]
8. Treatment of breast cancer in countries with limited resources.
Carlson RW; Anderson BO; Chopra R; Eniu AE; Jakesz R; Love RR; Masetti R; Schwartsmann G;
Breast J; 2003; 9 Suppl 2():S67-74. PubMed ID: 12713499
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
Smith IE; Dowsett M; Ebbs SR; Dixon JM; Skene A; Blohmer JU; Ashley SE; Francis S; Boeddinghaus I; Walsh G;
J Clin Oncol; 2005 Aug; 23(22):5108-16. PubMed ID: 15998903
[TBL] [Abstract][Full Text] [Related]
10. Surgical issues surrounding use of aromatase inhibitors.
Dixon JM; Renshaw L; Murray J; Macaskill EJ; Young O; Miller WR
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):97-103. PubMed ID: 16023854
[TBL] [Abstract][Full Text] [Related]
11. Endocrine and clinical endpoints of exemestane as neoadjuvant therapy.
Miller WR; Dixon JM
Cancer Control; 2002; 9(2 Suppl):9-15. PubMed ID: 11965226
[TBL] [Abstract][Full Text] [Related]
12. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].
Novoa Vargas A; Font López KC; Amador DD
Ginecol Obstet Mex; 2011 Sep; 79(9):553-7. PubMed ID: 21966856
[TBL] [Abstract][Full Text] [Related]
13. The prevention, detection, and management of breast cancer.
Houssami N; Cuzick J; Dixon JM
Med J Aust; 2006 Mar; 184(5):230-4. PubMed ID: 16515434
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant endocrine therapy for breast cancer: an overlooked option?
Wong ZW; Ellis MJ
Oncology (Williston Park); 2004 Apr; 18(4):411-20; discussion 421, 424, 429 passim. PubMed ID: 15134351
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant endocrine therapy in breast cancer.
Abrial C; Mouret-Reynier MA; Curé H; Feillel V; Leheurteur M; Lemery S; Le Bouëdec G; Durando X; Dauplat J; Chollet P
Breast; 2006 Feb; 15(1):9-19. PubMed ID: 16230013
[TBL] [Abstract][Full Text] [Related]
16. Safely promoting breast-conserving surgery and preventing early relapses with an aromatase inhibitor.
Markopoulos C
Surg Oncol; 2008 Aug; 17(2):113-28. PubMed ID: 18178077
[TBL] [Abstract][Full Text] [Related]
17. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
18. Facilitating breast-conserving surgery and preventing recurrence: aromatase inhibitors in the neoadjuvant and adjuvant settings.
Mamounas EP
Ann Surg Oncol; 2008 Mar; 15(3):691-703. PubMed ID: 18196346
[TBL] [Abstract][Full Text] [Related]
19. Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer.
Buzdar AU
Oncologist; 2003; 8(4):335-41. PubMed ID: 12897330
[TBL] [Abstract][Full Text] [Related]
20. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
Gibson LJ; Dawson C; Lawrence DH; Bliss JM
Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
